Toth Financial Advisory Corp boosted its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 13.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 59,937 shares of the company’s stock after acquiring an additional 7,124 shares during the period. Toth Financial Advisory Corp’s holdings in Colgate-Palmolive were worth $5,114,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alkeme Wealth LLC lifted its position in Colgate-Palmolive by 15.0% in the 3rd quarter. Alkeme Wealth LLC now owns 11,367 shares of the company’s stock valued at $970,000 after acquiring an additional 1,481 shares in the last quarter. Chickasaw Capital Management LLC boosted its stake in Colgate-Palmolive by 6.8% during the 3rd quarter. Chickasaw Capital Management LLC now owns 9,094 shares of the company’s stock valued at $776,000 after purchasing an additional 576 shares during the last quarter. Venture Visionary Partners LLC raised its stake in shares of Colgate-Palmolive by 335.9% in the third quarter. Venture Visionary Partners LLC now owns 54,703 shares of the company’s stock worth $4,667,000 after purchasing an additional 42,153 shares during the last quarter. Elevation Wealth Partners LLC lifted its stake in Colgate-Palmolive by 53.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 3,752 shares of the company’s stock valued at $320,000 after acquiring an additional 1,304 shares in the last quarter. Finally, Retirement Wealth Solutions LLC purchased a new position in Colgate-Palmolive during the third quarter worth about $63,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
Shares of CL stock traded up $0.72 during trading on Thursday, hitting $87.93. The company had a trading volume of 1,261,403 shares, compared to its average volume of 5,688,848. The stock’s 50-day moving average is $89.23 and its two-hundred day moving average is $88.75. The stock has a market capitalization of $70.09 billion, a price-to-earnings ratio of 34.98, a price-to-earnings-growth ratio of 4.07 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is 84.13%.
Wall Street Analyst Weigh In
Several analysts have commented on CL shares. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Weiss Ratings cut Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Finally, JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a report on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $98.65.
Get Our Latest Stock Report on CL
Insider Activity at Colgate-Palmolive
In related news, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. The trade was a 13.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Noel Wallace sold 161,021 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares in the company, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Corporate insiders own 0.43% of the company’s stock.
Colgate-Palmolive Profile
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
- These 3 ETFs Could Benefit From the Parts of Inflation That Won’t Go Away
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
